Suppr超能文献

血管外科患者围手术期停用慢性β受体阻滞剂治疗时与死亡率相关的因素:一项配对病例对照研究。

Factors associated with mortality when chronic betablocker therapy is withdrawn in the peri-operative period in vascular surgical patients: a matched case-control study.

作者信息

Biccard B M

机构信息

Department of Anaesthetics, Nelson R Mandela School of Medicine and Inkosi Albert Luthuli Central Hospital, Durban, South Africa.

出版信息

Cardiovasc J Afr. 2010 Mar-Apr;21(2):97-102.

Abstract

BACKGROUND

Withdrawal of chronic beta-blockade following vascular surgery is associated with peri-operative mortality. The aim of this study was to examine risk factors associated with mortality in patients where chronic beta-blockade was withdrawn.

METHODS

Two matched case-control studies were conducted, one of patients withdrawn from beta-blockade who survived and the other of patients who were maintained on beta-blockade and survived. Each case was matched with two controls. Three potential risk factors were analysed: the increase in heart rate postoperatively, the use of inotropes, and whether withdrawal for the first three postoperative days was more predictive than withdrawal for a single day. Multivariate conditional logistic regression was conducted.

RESULTS

The only independent predictor of in-hospital mortality was a change in the mean daily heart rate of > or = six beats per minute from the day of surgery to the third postoperative day, or death or discharge if this happened before the third day (OR 13.7, 95% CI: 1.7-110, p = 0.014). The area under the curve for the receiver operating characteristic curve was 0.787.

CONCLUSION

Use of a postoperative heart rate threshold may be clinically useful as an 'early warning system' in patients withdrawn from chronic beta-blockade in the peri-operative period.

摘要

背景

血管手术后停用慢性β受体阻滞剂与围手术期死亡率相关。本研究的目的是检查停用慢性β受体阻滞剂患者的死亡相关危险因素。

方法

进行了两项匹配的病例对照研究,一项研究对象为停用β受体阻滞剂后存活的患者,另一项研究对象为继续使用β受体阻滞剂并存活的患者。每个病例与两个对照进行匹配。分析了三个潜在危险因素:术后心率增加、使用血管活性药物,以及术后前三天停用β受体阻滞剂是否比单日停用更具预测性。进行了多变量条件逻辑回归分析。

结果

住院死亡率的唯一独立预测因素是从手术当天到术后第三天平均每日心率每分钟增加≥6次,或者如果在此之前发生则为死亡或出院(比值比13.7,95%可信区间:1.7 - 110,p = 0.014)。受试者工作特征曲线下面积为0.787。

结论

在围手术期停用慢性β受体阻滞剂的患者中,使用术后心率阈值作为“早期预警系统”可能具有临床实用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e89/3721290/f70c4093f22a/cvja-21-99-g001.jpg

相似文献

3
Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):116-20. doi: 10.1016/j.archger.2007.11.003. Epub 2008 Jan 4.
4
Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome.
J Am Coll Cardiol. 2010 Nov 30;56(23):1922-9. doi: 10.1016/j.jacc.2010.05.056.
6
Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.
Ann Vasc Surg. 2013 May;27(4):537-45. doi: 10.1016/j.avsg.2012.12.001. Epub 2013 Mar 25.
9
Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery.
Anesthesiology. 2000 Jul;93(1):129-40. doi: 10.1097/00000542-200007000-00023.

本文引用的文献

3
Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients.
Eur J Vasc Endovasc Surg. 2007 Jan;33(1):13-9. doi: 10.1016/j.ejvs.2006.06.019. Epub 2006 Aug 24.
4
Value of immediate postoperative electrocardiogram to update risk stratification after major noncardiac surgery.
Am J Cardiol. 2004 Oct 15;94(8):1017-22. doi: 10.1016/j.amjcard.2004.06.057.
6
Physiological abnormalities in early warning scores are related to mortality in adult inpatients.
Br J Anaesth. 2004 Jun;92(6):882-4. doi: 10.1093/bja/aeh113. Epub 2004 Apr 2.
8
Cardiac scoring systems--what is their value?
Anaesthesia. 2003 Oct;58(10):985-91. doi: 10.1046/j.1365-2044.2003.03342.x.
9
Circadian variation in myocardial ischemia: the possible mechanisms involving in this phenomenon.
Med Hypotheses. 2003 Aug;61(2):240-3. doi: 10.1016/s0306-9877(03)00154-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验